- Home
- GHRS vs CRTO Comparison
GHRS vs CRTO Comparison
Compare GHRS & CRTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GHRS | CRTO |
|---|---|---|
| Founded | 2018 | 2005 |
| Country | Ireland | France |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Advertising |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 980.6M |
| IPO Year | 2021 | 2013 |
Fundamental Metrics
Financial Performance| Metric | GHRS | CRTO |
|---|---|---|
| Price | $13.87 | $17.69 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 10 |
| Target Price | ★ $41.38 | $35.90 |
| AVG Volume (30 Days) | 205.3K | ★ 267.0K |
| Earning Date | 03-05-2026 | 05-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 38.95 |
| EPS | N/A | ★ 2.64 |
| Revenue | N/A | ★ $2,296,692,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $5.62 |
| P/E Ratio | ★ N/A | $6.68 |
| Revenue Growth | N/A | ★ 27.65 |
| 52 Week Low | $7.98 | $16.15 |
| 52 Week High | $19.51 | $37.26 |
Technical Indicators
Market Signals| Indicator | GHRS | CRTO |
|---|---|---|
| Relative Strength Index (RSI) | 40.10 | 44.89 |
| Support Level | $12.14 | $16.15 |
| Resistance Level | $14.80 | $21.32 |
| Average True Range (ATR) | 0.84 | 0.75 |
| MACD | -0.23 | -0.05 |
| Stochastic Oscillator | 25.61 | 31.67 |
Price Performance
Historical ComparisonAbout GHRS GH Research PLC
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.
About CRTO Criteo S.A.
Criteo SA is an ad-tech company in the digital advertising market. Its technology, allows retailer advertisers to launch multichannel and cross-device marketing campaigns in real time. With real-time return on investment analysis of the ads, the firm's clients can adjust their marketing strategies dynamically. It has two reportable segments: Retail Media and Performance Media. The firm also provides technology allowing retailers to effectively manage their ad inventories and improve yield optimization.